Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer
Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer
复制标题
DOI：
10.1097/sla.0b013e3181454171
复制
发表时间：
2007-12-01
影响因子：
9
通讯作者：
Kubota, Keiichi
中科院分区：
文献类型：
--
作者：
Ishizuka, Mitsuru;Nagata, Hitoshi;Kubota, Keiichi
目的：探讨术前格拉斯哥预后评分（GPS）对结直肠癌患者术后预后判断的意义。背景：最近的研究表明，GPS是一种基于炎症的预后评分，仅包括C反应蛋白（CRP）和白蛋白，是预测癌症患者术后预后的有用工具。方法：根据以下入院资料计算GPS：CRP（>10 mg/L）和低白蛋白血症（Alb）均升高的患者（10例），其中10例患者（12例）的GPS为正常值，10例患者（12例）的GPS为正常值，10例患者（12例）的GPS为正常值
Objective: To investigate the significance of preoperative Glasgow prognostic score (GPS) for postoperative prognostication of patients with colorectal cancer.Background: Recent studies have revealed that the GPS, an inflammation-based prognostic score that includes only C-reactive protein (CRP) and albumin, is a useful tool for predicting postoperative outcome in cancer patients. However, few studies have investigated the GPS in the field of colorectal surgery.Methods: The GPS was calculated on the basis of admission data as follows: patients with an elevated level of both CRP (>10 mg/L) and hypoalbuminemia (Alb